TMCnet

Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced preclinical data highlighting an ...
News Medical

How Process Development Enhances Drug Discovery Outcomes

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...
National Academies of Sciences%2c Engineering%2c and Medicine

FEDERAL AGENCY ROLES IN CANCER DRUG DEVELOPMENT FROM PRECLINICAL RESEARCH TO NEW DRUG APPROVAL:

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...
Technology Networks

Organoid Screening Models in Drug Discovery

Organoid screening platforms are transforming drug discovery by providing physiologically relevant 3D models that improve ...
Drug Target Review

From leaderboards to lab notebooks: AI designs reach preclinical testing

For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...
Nature

Preclinical pitfalls: How to avoid costly formulation failures

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...
EurekAlert!

Insilico Medicine announces developmental candidate benchmarks and timelines for novel therapeutics discovered using generative AI

Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
Healthline

The FDA Development and Approval Process for Medications and Medical Devices

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

WuXi AppTec’s CRDMO Model: Integrating Research, Development, and Manufacturing into a Unified Platform

SAN DIEGO , CA, UNITED STATES, April 17, 2026 /EINPresswire.com/ -- In today’s life sciences landscape, the journey ...

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

Mouse analog of MICVO (maMICVO) monotherapy produced dose-dependent inhibition of tumor growth in a syngeneic preclinical model of HNSCCmaMICVO ...
The Next Web

Will AI revolutionise drug development? Researchers say it depends on how it’s used!

From survivorship bias to root causes! Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening ...
Nasdaq

ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery

TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that it has successfully ...